|
Kanatbekova Zh.K., Shakhanov A.V., Uryasyev O.M., Nikiforov A.A.
Clinical significance of determining nitric oxide synthesis regulators in chronic obstructive pulmonary disease in comorbidity with arterial hypertension
|
№6 / 2024
|
|
Sycheva A.S., Malyavina M.A., Tebueva L.V., Grigorievsky E.D., Kebina A.L., Vertkin A.L., Solodov A.A., Semenyakin I.V., Levchenko O.V., Yanushevich O.O.
Peculiarities of COVID-19 coronavirus infection course in patients with comorbid pathology
|
№6 / 2022
|
|
Shevtsova V.I., Kurguzova A.S., Dobrynina I.S.
The effectiveness of dispensary observation of patients with hypertension
|
№4 (приложение) / 2022
|
|
Pertsev A.V., Rezova N.V., Shkatova Ya.S.
Influence of antihypertensive therapy on affected target organs in hypertension disease
|
№4 (приложение) / 2022
|
|
Yesina E.Yu., Zuikova A.A., Kotova Yu.A.
The relationship of environmental risk factors and cardiovascular diseases in hypertensive patients living in rural areas
|
№4 (приложение) / 2022
|
|
Heylo T.S., Danilogorskaya Yu.A., Nazarenko G.B., Gladysheva E.G.
Dynamics of microcirculation indices in patients with chronic ischemic diseases of the central nervous and cardiovascular systems
|
№8 / 2021
|
|
Heylo T.S., Danilogorskaya Yu.A., Nazarenko G.B., Martynov A.I.
Estimation of the influence of 6 week therapy by meldonium (Mildronate®) at bulbar capillaroscopy indexes in chronic ischemic heart and brain disease female patient
|
№3 / 2020
|
|
Chulkov V.S., Lenetz E.A.
Sartans: from treatment of hypertension to management of cardiovascular risk
|
№7 / 2019
|
|
Mazurov V.I., Petrova M.S., Gaydukova I.Z., Inamova O.V., Fonturenko A.Yu., Gaydukova E.K., Shapovalov A.A., Nagirnyak I.M.
Features of gouty arthritis according to the St. Petersburg City register of gout (2016–2018 years)
|
№6 / 2019
|
|
Vyalkina N.A., Klyashev S.M., Vyalkina Y.A., Mezhonov E.M., Klyasheva Y.M.
Peculiarities of the daily profile of arterial pressure and its impact on the outcomes of patients with chronic kidneys disease, receiving program hemodialysis
|
№2 / 2019
|
|
Chulkov Vl.S., Vereina N.K., Chulkov V.S., Tarasova O.A., Sinitsyn S.P.
Hemostais, adipokines, rennin-angiotensin system gene polymorphisms and target organ damage in young patients with hypertension and abdominal obesity
|
№1 / 2019
|
|
Solovieva K.B., Shalenkova M.A., Dolbin I.V.
Estimating the compliance levels dynamic in hypertensive patients with first-second stage and first-third grades
|
№1 / 2019
|
Русский
